Myostatin antisense administration prevents sepsis‐induced muscle atrophy and weakness in male mice
Physiological Reports · 2025
DOI: 10.14814/phy2.70566 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2025. Verfasst von Nobuto Nakanishi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Disaster and Emergency Medicine, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan. Hauptthemen laut MEDLINE: Myostatin, Muscular Atrophy, Sepsis, Muscle Weakness. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science London (JSPS).
Themen: Sepsis
Abstract (Originalsprache)
Muscle atrophy and weakness are serious problems associated with sepsis. However, only a few pharmacological interventions are available to date. In this study, myostatin antisense was used to prevent sepsis‐induced muscle atrophy and weakness. Sepsis was induced in 8‐week‐old male C57BL/6J mice via intraperitoneal injection of 1 mg/g cecal slurry (CS). Myostatin antisense was injected into the right tibialis anterior muscle. Myostatin mRNA was measured in the tibialis anterior and quadriceps femoris muscles on Day 1. The body weight, grip strength, and cross‐sectional area of the tibialis anterior muscle were measured on Day 6. The administration of myostatin antisense decreased myostatin expression on Day 1 in the injected side (0.023 ± 0.010 in CS vs. 0.008 ± 0.002 in CS + antisense) as well as in the noninjected muscles. It also decreased the myostatin protein level (2.0 ± 0.3 in CS vs. 1.2 ± 0.5 in CS + antisense, p = 0.04). Body weight reduction (94.9% ± 2.0% vs. 98.2% ± 1.8%, p < 0.01) and grip strength reduction (77.0% ± 12.3%vs. 89.8% ± 8.3%, p = 0.04) were suppressed by the injection. The cross‐sectional area of the right tibialis anterior muscle increased after the treatment (1116 ± 530 μm 2 vs. 1435 ± 648 μm 2 , p < 0.01). Myostatin antisense suppressed the elevation of myostatin mRNA expression in whole muscles of mice with sepsis and prevented sepsis‐induced muscle atrophy and weakness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Disaster and Emergency Medicine, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
- Quality Assurance Section, Pharmaceutical Quality Assurance Dept., KNC Laboratories Co., Ltd., Izumo, Shimane, Japan.
- Division of Rehabilitation Medicine, Kobe University Hospital, Kobe, Hyogo, Japan.
- Division of Rehabilitation, Sapporo Medical University Hospital, Sapporo, Hokkaido, Japan.
- Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama, Japan.
- Graduate School of Science, Technology and Innovation, Kobe University, Kobe, Hyogo, Japan.
ORCID-Profile: Nobuto Nakanishi
Förderung
- Japan Society for the Promotion of Science London (JSPS)
Zitieren
APA
Nakanishi, N., Maeta, K., Ono, Y., Hirabayashi, T., Tatebayashi, D., Nakamura, K., Inoue, S., Matsuo, M., & Kotani, J. (2025). Myostatin antisense administration prevents sepsis‐induced muscle atrophy and weakness in male mice. Physiological Reports. https://doi.org/10.14814/phy2.70566
Vancouver
Nakanishi N, Maeta K, Ono Y, Hirabayashi T, Tatebayashi D, Nakamura K, et al. Myostatin antisense administration prevents sepsis‐induced muscle atrophy and weakness in male mice. Physiological Reports. 2025. doi:10.14814/phy2.70566
BibTeX
@article{Nakanishi2025,
author = {Nakanishi, Nobuto and Maeta, Kazuhiro and Ono, Yuko and Hirabayashi, Takumi and Tatebayashi, Daisuke and Nakamura, Kensuke and Inoue, Shigeaki and Matsuo, Masafumi and Kotani, Joji},
title = {Myostatin antisense administration prevents sepsis‐induced muscle atrophy and weakness in male mice},
journal = {Physiological Reports},
year = {2025},
doi = {10.14814/phy2.70566}
}
EUVIMED